Wockhardt’s new oral antibiotic gets CDSCO approval
Pharmaceuticals firm Wockhardt Ltd on Thursday (January 2) announced that the Central Drugs Standard Control Organization (CDSCO) has approved Miqnaf (nafithromycin) as a new treatment for Community-Acquired Bacterial Pneumonia (CABP)...